SOPHiA GENETICS and Element Biosciences have announced a partnership to combine Element's AVITI sequencing systems with SOPHiA GENETICS' AI-driven analytics platform. The collaboration aims to streamline genomic workflows and accelerate research in precision medicine by making advanced sequencing and data analysis more accessible to healthcare organizations worldwide. Both companies emphasize that the integration will deliver richer insights, faster results, and greater scalability, supporting the global expansion of precision medicine initiatives.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via PR Newswire (Ref. ID: NE20304) on November 11, 2025, and is solely responsible for the information contained therein.